We are live on ! Find out more
UBS Group

UBS Group Portfolio holdings

AUM $666B
1-Year Est. Return 30.12%
 

UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.

This Fund
S&P 500
This Quarter Est. Return
+4.2%
1 Year Est. Return
+30.12%
3 Year Est. Return
+86.21%
5 Year Est. Return
+101.56%
10 Year Est. Return
+367.78%
AUM
$216B
AUM Growth
+$23B
Cap. Flow
+$15.2B
Cap. Flow %
7.01%
Top 10 Hldgs %
16.18%
Holding
8,493
New
749
Increased
3,978
Reduced
2,659
Closed
707

Sector Composition

Rank Sector Weight
1 Financials 7.19%
2 Technology 6.4%
3 Healthcare 6.06%
4 Industrials 4.94%
5 Consumer Discretionary 4.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LJPC
3976
DELISTED
La Jolla Pharmaceutical Company
LJPC
$667K ﹤0.01%
19,163
-9,552
-33% -$307K
ORA icon
3977
Ormat Technologies
ORA
$6.6B
$666K ﹤0.01%
10,911
-4,315
-28% -$249K
CLDT
3978
Chatham Lodging
CLDT
$607M
$665K ﹤0.01%
31,160
+19,428
+166% +$396K
XLBS
3979
DELISTED
POWERSHARES S&P SMALLCAP MATERIALS PORT
XLBS
$665K ﹤0.01%
13,388
+783
+6% +$38.9K
GLQ
3980
Clough Global Equity Fund
GLQ
$155M
$664K ﹤0.01%
50,107
+22,987
+85% +$305K
HLI icon
3981
Houlihan Lokey
HLI
$8.92B
$664K ﹤0.01%
16,949
-330
-2% -$12.1K
ACN icon
3982
PUT
Accenture
ACN
$105B
$662K ﹤0.01%
4,900
-50,700
-91% -$6.61M
EMGF icon
3983
iShares Emerging Markets Equity Factor ETF
EMGF
$1.86B
$662K ﹤0.01%
14,154
+6,588
+87% +$300K
JHG
3984
DELISTED
Janus Henderson
JHG
$658K ﹤0.01%
18,890
-17,707
-48% -$602K
INVX
3985
Innovex International
INVX
$2.15B
$657K ﹤0.01%
14,878
+2,233
+18% +$97.2K
NEWR
3986
DELISTED
New Relic, Inc.
NEWR
$657K ﹤0.01%
13,204
-145,274
-92% -$6.86M
TUZ
3987
DELISTED
PIMCO 1-3 Year U.S. Treasury Index Exchange-Traded Fund
TUZ
$657K ﹤0.01%
12,988
+731
+6% +$37.1K
BMVP icon
3988
Invesco Bloomberg MVP Multi-factor ETF
BMVP
$106M
$656K ﹤0.01%
21,645
+2,667
+14% +$78K
GEN icon
3989
CALL
Gen Digital
GEN
$16.8B
$656K ﹤0.01%
20,000
PGRE
3990
DELISTED
Paramount Group
PGRE
$654K ﹤0.01%
40,837
+22,865
+127% +$363K
OIA icon
3991
Invesco Municipal Income Opportunities Trust
OIA
$288M
$653K ﹤0.01%
82,710
-2,283
-3% -$18K
FEO
3992
DELISTED
First Trust/abrdn Emerging Opportunity Fund
FEO
$652K ﹤0.01%
39,084
+3,892
+11% +$65.6K
HEEM icon
3993
iShares Currency Hedged MSCI Emerging Markets
HEEM
$279M
$650K ﹤0.01%
25,232
-495
-2% -$12.5K
ROG icon
3994
Rogers Corp
ROG
$2.39B
$649K ﹤0.01%
4,869
+2,491
+105% +$295K
ASPS icon
3995
CALL
Altisource Portfolio Solutions
ASPS
$66M
$647K ﹤0.01%
3,125
+125
+4% +$23.3K
CHDN icon
3996
Churchill Downs
CHDN
$6.06B
$647K ﹤0.01%
18,804
-254,196
-93% -$8.14M
PETS icon
3997
PetMed Express
PETS
$42.1M
$647K ﹤0.01%
19,501
+2,210
+13% +$90K
CALA
3998
DELISTED
Calithera Biosciences, Inc
CALA
$646K ﹤0.01%
2,051
+772
+60% +$244K
NEOS
3999
DELISTED
Neos Therapeutics, Inc
NEOS
$645K ﹤0.01%
70,462
-174,516
-71% -$1.33M
DNR
4000
DELISTED
Denbury Resources, Inc.
DNR
$645K ﹤0.01%
480,987
-562,506
-54% -$733K

Similar funds

UBS Group's Q3 2017 Portfolio in Review

As of Q3 2017, UBS Group held 8,493 positions worth $216B, up 12% from $193B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

UBS Group deployed $15.2B of net new capital in Q3 2017, opening 749 new positions and adding to 3,978 existing holdings. Its largest new stake was Baker Hughes: 613,477 shares worth $22.5M.

By sector, the portfolio is most concentrated in Financials at 7.2% of assets, down from 7.7% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Monsanto Co, an estimated $658M trimmed.

  • UBS Group's largest Q3 2017 buy was Baker Hughes: 613,477 shares worth $22.5M.
  • UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $422M increase.
  • UBS Group's biggest Q3 2017 reduction was Monsanto Co, cutting an estimated $658M.
  • UBS Group fully exited Oneok Partners LP in Q3 2017, selling an estimated $218M.
  • UBS Group's ten largest holdings make up 16% of its $216B portfolio in Q3 2017.
  • UBS Group opened 749 new positions and closed 707 in Q3 2017.
  • UBS Group's portfolio value rose 12% quarter-over-quarter to $216B.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.